Physician profile
Radhika Mathur
NPI 1073582268
$5,389.83
in general payments reported to CMS, 2019-2025
36 companies · $718 in 2025
The $718 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $149 · 2021: $477 · 2022: $1,053 · 2023: $804 · 2024: $930 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,438 · Education: $14.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,437.53 |
| Education | $14.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $712.35 | 2019-2025 | |
| Novo Nordisk INC | $701.42 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $634.54 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $508.83 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $444.99 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $315.73 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.55 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $265.12 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $249.13 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $213.32 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Abbott Laboratories | $151.17 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $109.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $105.65 | 2020-2025 | |
| Astellas Pharma US INC | $55.14 | 2019-2025 | Veozah |
| Corium, LLC | $51.86 | 2023-2025 | Azstarys, Adlarity |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $49.47 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.19 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $47.87 | 2019-2022 | |
| Lifescan, INC. | $43.48 | 2021-2022 | |
| Nevro Corp. | $41.00 | 2022 | |
| Dynavax Technologies Corporation | $32.43 | 2021-2024 | Heplisav-B |
| Grt US Holding, INC. | $32.21 | 2022 | |
| Idorsia Pharmaceuticals US INC | $29.47 | 2022-2024 | Quviviq |
| Madrigal Pharmaceuticals | $27.99 | 2025 | Rezdiffra |
| Avanir Pharmaceuticals, INC. | $26.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.30 | 2019-2021 | |
| Sanofi Pasteur INC. | $24.76 | 2019-2020 | |
| Gilead Sciences, INC. | $21.38 | 2025 | |
| Alexion Pharmaceuticals, INC. | $20.94 | 2020 | |
| Lundbeck LLC | $17.18 | 2022 | |
| Tactile Systems Technology INC | $16.14 | 2024 | Flexitouch Plus, Entre Plus |
| Shire North American Group INC | $14.89 | 2019 | |
| Radius Health, INC. | $13.48 | 2019 | |
| Currax Pharmaceuticals LLC | $13.42 | 2021 | |
| Mylan Specialty L.P. | $13.07 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhika Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.